As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...
Uniogen's progress toward clinical commercialization aligns with larger internal goals of bringing cancer diagnostics to market, with a specific focus on women's health.
SALT LAKE CITY, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will present new data in eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback